JK Lakshmi Cement Ltd
JKLAKSHMIJK Lakshmi Cement Ltd is cheap for a reason. The P/E sits at the 29th percentile of its own range, and the quarters are still getting worse.
The sharpest disagreement: annual EPS moved +41.1% against a −43.9% price move — the market has not yet caught up with the delivery.
The price is in a downtrend (43 weeks in) while the P/E sits at the 29th percentile of its own 11-year range. Underneath, the last four quarters read deteriorating — profit −28.0% year on year, and 235% of the last 3 years' profit arrived as cash. What settles it: whether the price catches up with earnings that have already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
JK Lakshmi Cement Ltd trades at ₹506, in a downtrend and 43 weeks into that stage. That is −21.2% against its own 200-day average. It sits at 0% of a 52-week range of ₹506 to ₹870. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (37 weeks and counting).
Today the stock is in a downtrend — week 43 of stage 4, confirmed. At ₹506 it trades −21.2% versus its 200-day average and sits at 0% of its 52-week range (₹506–₹870).
Against the market, two honest reads. Cumulative: over the last 10.5 years the stock moved +70% while the NIFTY 500 moved +267% — behind the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (37 weeks and counting; last ahead the week of 2026-01-16) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
JK Lakshmi Cement Ltd trades at 16.3× P/E, near the bottom of its own range — cheaper only 29% of the time. Its long-run median P/E is 21.6×, measured across 10.5 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 16.3× is near the bottom of its own range — cheaper only 29% of the time, against a long-run median of 21.6× measured over 10.5 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved +41.1% against a −43.9% price move — earnings outran the price, pushing the multiple DOWN its own range.
The price move, decomposed: over 5y, of the −6.7%/yr price move, ~−6.7%/yr came from earnings growth and ~+0.0 pp from the multiple (roughly flat); over 10y, of the +0.6%/yr price move, ~+9.9%/yr came from earnings growth and ~−9.3 pp from the multiple (compressing). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is low against its own past, so the story rests on the earnings line underneath it, not the multiple.
The PEG ratio and its quarterly curve, which only the second data source carries, are not drawn on this page: its two data sources disagree by up to 53% on reported income across 14 comparable periods. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.
Stage: Turning around Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
JK Lakshmi Cement Ltd reads as turning around on its fundamental arc. Turning around — profit growth swung from −40.4% at the trough to +0.5% off a 5-quarter-old trough, ROCE holding at 12.0%. The read is built from 8 quarters across 4 curves, on partial evidence.
Why it matters: growth inflections are where re-ratings start — the curves say a turn is forming, so the question becomes whether the next quarters confirm it.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +9.2% | +1.6% | +7.4% | +9.9% |
| Profit | +49.6% | +3.8% | −0.4% | +59.0% |
| EPS | +41.1% | +2.9% | −0.7% | +77.0% |
| Share price | −43.9% | −9.4% | −6.7% | +0.6% |
4-Factor Sector Score
44.8/100 — rank 13 of 26 in Cement · 69% evidence confidence
JK Lakshmi Cement Ltd scores 44.8 out of 100 against the 26 companies it is compared with in Cement, ranking 13. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 14.6 + 14.1 + 10.7 + 5.4 = 44.8. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
JK Lakshmi Cement Ltd reported ₹1,905 Cr of revenue in the Jun 26 quarter, +9.4% year on year. That is the 6th straight quarter of year-on-year growth. Over 10 years it has compounded at 9.9% a year. The last full year, FY26, came in at ₹6,763 Cr. The last four reported quarters add to ₹6,927 Cr.
FY26 revenue came in at ₹6,763 Cr (+9.2% on the year), capping 10 years at 9.9% compound. The latest quarter (Jun 26) printed ₹1,905 Cr, +9.4% year on year — the 6th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +10.0% growth against the decade's 9.9% — the current year is running in line with its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +8.7% over the last 4 quarters against +2.3%/yr over the last 8 — accelerating; TTM profit +0.5% vs −10.7%/yr — accelerating.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
JK Lakshmi Cement Ltd's operating margin is 14.0% in the Jun 26 quarter, −4.0 percentage points against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 10.0% to 20.0%. The current quarter sits inside that band.
The latest quarter's operating margin is 14.0%, −4.0 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 10.0%–20.0%.
🚨 Why the margin moved: operating margin went −4.3 pp year on year while gross margin went −4.1 pp — the loss came mostly from the gross line: input costs and pricing.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
JK Lakshmi Cement Ltd earned ₹108 Cr of net profit in the Jun 26 quarter, −28.0% year on year. Full-year FY26 profit was ₹413 Cr. The 10-year compound rate is 59.0%. That is 5.7% of the quarter's revenue. The same quarter a year earlier earned ₹150 Cr. 1 of the last 12 reported quarters were loss-making.
Jun 26 profit was ₹108 Cr, −28.0% year on year. On the full year, FY26 printed ₹413 Cr (+49.6%), and the 10-year compound rate is 59.0%.
🚨 Why profit moved: revenue contributed +9.4% and the margin −4.0 pp — the quarter was revenue-led despite a thinner margin.
Pace comparison, last four quarters: profit −26.9% vs revenue +10.0%. Profit is growing slower than sales — costs are eating the growth before it reaches the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 235% of JK Lakshmi Cement Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹1,082 Cr of operating cash against ₹413 Cr of profit. After ₹130 Cr of capital spending, ₹952 Cr was left as free cash.
FY26: operating cash of ₹1,082 Cr against reported profit of ₹413 Cr, leaving free cash of ₹952 Cr after ₹130 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 235% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why conversion sits at 235%: the cash cycle stretched 72 days between FY21 and FY26 — more of each rupee of profit waits inside the cycle before arriving.
Router verdict: the bigger cash user is investment — capital spending ran 2.4× depreciation over three years, so the next section's job is to check what that build-out is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
JK Lakshmi Cement Ltd's cash conversion cycle runs 57 days in FY26, up from −15 days in FY21. Capital spending ran ₹2,090 Cr over the last 3 years. At FY26 sales of ₹6,763 Cr each day of that cycle holds about ₹18.5 Cr, so roughly ₹1,056 Cr sits inside the business at any moment.
FY26: debtors at 6 days, inventory at 184 days — roughly 6.1 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 57 days, looser than FY21's −15.
The full loop: cash goes out to suppliers and production on day 0; stock waits 184 days to sell; customers pay about 6 days after that; and suppliers themselves are paid at 133 days — netting out to the 57-day cycle.
In money terms: at FY26 sales of ₹6,763 Cr, each day of the cycle holds about ₹18.5 Cr — so the 57-day loop keeps roughly ₹1,056 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹2,090 Cr over the last 3 fiscal years against ₹869 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹277 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.
JK Lakshmi Cement Ltd earns a ROCE of 12% in FY26. That is up from a trough of 4% in FY16. A return-on-invested-capital spread against the cost of capital is not computable from what is held here. The wiring behind it is 6.1% net margin on 0.79× asset turns.
FY26 ROCE is 12%, recovered from a FY16 trough of 4% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY26): 6.1% net margin × 0.79× asset turns × 2.20× balance-sheet leverage ≈ 10.6% on equity. Margin does its share; leverage is a meaningful part of the equation.
The quarterly return curves and the return-on-invested-capital overlay, which only the second data source carries, are not drawn on this page: its two data sources disagree by up to 53% on reported income across 14 comparable periods. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.
Debt Debt-to-equity says how much of the business is funded by borrowings; interest cover says how many times operating profit pays the interest bill. Low and high, respectively, is the safe corner.
JK Lakshmi Cement Ltd carries ₹2,586 Cr of borrowings against ₹3,886 Cr of equity in FY26, a debt-to-equity of 0.67. Operating profit covers the interest bill 5×. Over 5 years borrowings went from ₹1,672 Cr to ₹2,586 Cr. Capital spending ran ₹2,090 Cr across the last 3 of those years.
FY26: borrowings of ₹2,586 Cr against equity of ₹3,886 Cr — a debt-to-equity of 0.67. Operating profit covers the interest bill 5×. Over 5 years borrowings went from ₹1,672 Cr to ₹2,586 Cr while capital spending ran ₹2,090 Cr in just the last 3 — part of the build-out is riding on borrowed money.
The total-debt and debt-to-equity series, which only the second data source carries, are not drawn on this page: its two data sources disagree by up to 53% on reported income across 14 comparable periods. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Foreign institutions cut 2.7 points of JK Lakshmi Cement Ltd over 8 quarters, the biggest move on the register. That takes foreign institutions to 8.6% of the company. Promoters moved −1.2 points over the same window, to 45.1%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Foreign institutions: −2.7 points over 8 quarters to 8.6%; Promoters: −1.2 points over 8 quarters to 45.1%; Domestic institutions: +1.2 points over 8 quarters to 26.6%.
🚨 Why the register moved: foreign institutions drove it (−2.7 points), alongside promoters (−1.2 points) — distribution into the market’s bid.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
JK Lakshmi Cement Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Star Cement LtdSTARCEMENT | 69.7/100Favorable setup94% evidence | BASING | 25.6/35 Revenue 14.5% · PAT 55.1% · OPM change -4 pp 100% evidence | 20.2/25 ROCE 16.6% · OPM 21% 100% evidence | 11.0/20 P/E 20.9× · PEG 1.11 100% evidence | 12.9/20 RS sector 13.8% · RS bench -10.3% · 1Y -33.2%0 of 10 weeks ahead 70% evidence |
| Exact sum: 25.6 + 20.2 + 11 + 12.9 = 69.7 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 2NCL Industries LtdNCLIND | 66.9/100Favorable setup87% evidence | ASLEEP | 23.2/35 Revenue 3.7% · PAT 100% · OPM change -3 pp 95% evidence | 18.1/25 ROCE 14.6% · OPM 12% 95% evidence | 14.9/20 P/E 6.4× · PEG — 50% evidence | 10.7/20 RS sector 3.2% · RS bench -5.3% · 1Y -18.2%2 of 12 weeks ahead 100% evidence |
| Exact sum: 23.2 + 18.1 + 14.9 + 10.7 = 66.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3Rain Industries LtdRAIN | 64.7/100Mixed-positive evidence75% evidence | LEADER | 28.4/35 Revenue 17% · PAT 100% · OPM change 5 pp 95% evidence | 10.5/25 ROCE 8.3% · OPM 19% 76% evidence | 10.8/20 P/E 13.5× · PEG — 15% evidence | 15.0/20 RS sector 53% · RS bench 41.8% · 1Y 55.9%11 of 12 weeks ahead 100% evidence |
| Exact sum: 28.4 + 10.5 + 10.8 + 15 = 64.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4UltraTech Cement LtdULTRACEMCO | 63.5/100Mixed-positive evidence76% evidence | TURNING | 23.1/35 Revenue 17.2% · PAT 26.7% · OPM change -1 pp 95% evidence | 17.1/25 ROCE 12.7% · OPM 20% 76% evidence | 9.6/20 P/E 37.6× · PEG — 50% evidence | 13.7/20 RS sector 17% · RS bench -5.5% · 1Y -12.7%0 of 10 weeks ahead 70% evidence |
| Exact sum: 23.1 + 17.1 + 9.6 + 13.7 = 63.5 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 5Mangalam Cement LtdMANGLMCEM | 63.4/100Mixed-positive evidence100% evidence | TURNING | 18.1/35 Revenue 0.5% · PAT 90% · OPM change -5 pp 100% evidence | 10.5/25 ROCE 11% · OPM 12% 100% evidence | 15.2/20 P/E 21.7× · PEG 0.6 100% evidence | 19.6/20 RS sector 32.9% · RS bench 23% · 1Y 33.8%8 of 12 weeks ahead 100% evidence |
| Exact sum: 18.1 + 10.5 + 15.2 + 19.6 = 63.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Orient Cement LtdORIENTCEM | 58.1/100Mixed-positive evidence93% evidence | BASING | 17.9/35 Revenue -12.1% · PAT -19.3% · OPM change 3 pp 100% evidence | 16.9/25 ROCE 16.5% · OPM 24% 100% evidence | 16.1/20 P/E 12.1× · PEG 0.25 65% evidence | 7.2/20 RS sector -11.4% · RS bench -19.2% · 1Y -43.9%0 of 12 weeks ahead 100% evidence |
| Exact sum: 17.9 + 16.9 + 16.1 + 7.2 = 58.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7HeidelbergCement India LtdHEIDELBERG | 55.7/100Mixed-positive evidence100% evidence | TURNING | 15.7/35 Revenue 6.6% · PAT 2.6% · OPM change -4 pp 100% evidence | 14.8/25 ROCE 14.7% · OPM 11% 100% evidence | 13.2/20 P/E 27.9× · PEG 0.83 100% evidence | 12.0/20 RS sector -0.9% · RS bench -9.3% · 1Y -30.1%0 of 12 weeks ahead 100% evidence |
| Exact sum: 15.7 + 14.8 + 13.2 + 12 = 55.7 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 8Dalmia Bharat LtdDALBHARAT | 55.1/100Mixed-positive evidence94% evidence | BREAKING OUT | 14.1/35 Revenue 7.6% · PAT 0.4% · OPM change -3 pp 100% evidence | 13.2/25 ROCE 7.6% · OPM 21% 100% evidence | 15.1/20 P/E 29.8× · PEG 0.72 100% evidence | 12.7/20 RS sector 12.6% · RS bench -9.4% · 1Y -27.5%1 of 10 weeks ahead 70% evidence |
| Exact sum: 14.1 + 13.2 + 15.1 + 12.7 = 55.1 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 9JSW Cement LtdJSWCEMENT | 51.9/100Thin evidence · provisional52% evidence | ASLEEP | 19.2/35 Revenue 15.6% · PAT 100% · OPM change -5 pp 71% evidence | 11.8/25 ROCE 11.1% · OPM 16% 76% evidence | 10.6/20 P/E 20.6× · PEG — 15% evidence | 10.3/20 RS sector — · RS bench -4.9% · 1Y -20.8%3 of 10 weeks ahead 25% evidence |
| Exact sum: 19.2 + 11.8 + 10.6 + 10.3 = 51.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 10Nuvoco Vistas Corporation LtdNUVOCO | 49.5/100Mixed-negative evidence87% evidence | TURNING | 21.8/35 Revenue 9.5% · PAT 100% · OPM change 0 pp 100% evidence | 10.2/25 ROCE 7% · OPM 18% 100% evidence | 4.8/20 P/E 28.4× · PEG 8.14 65% evidence | 12.7/20 RS sector 3.6% · RS bench -2.8% · 1Y -28.8%5 of 10 weeks ahead 70% evidence |
| Exact sum: 21.8 + 10.2 + 4.8 + 12.7 = 49.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11J K Cements LtdJKCEMENT | 48.1/100Mixed-negative evidence94% evidence | TURNING | 11.9/35 Revenue 15.9% · PAT -7.1% · OPM change -5 pp 100% evidence | 16.7/25 ROCE 15.1% · OPM 16% 100% evidence | 8.0/20 P/E 38.3× · PEG 1.46 100% evidence | 11.5/20 RS sector 10.4% · RS bench -12.1% · 1Y -27%0 of 10 weeks ahead 70% evidence |
| Exact sum: 11.9 + 16.7 + 8 + 11.5 = 48.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 12Prism Johnson LtdPRSMJOHNSN | 47.2/100Mixed-negative evidence61% evidence | BASING | 18.1/35 Revenue 4.8% · PAT 100% · OPM change 2 pp 71% evidence | 6.9/25 ROCE 5.9% · OPM 12% 76% evidence | 9.2/20 P/E 48.6× · PEG — 15% evidence | 13.0/20 RS sector 14.3% · RS bench -10.5% · 1Y -22.4%0 of 10 weeks ahead 70% evidence |
| Exact sum: 18.1 + 6.9 + 9.2 + 13 = 47.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 13JK Lakshmi Cement Ltdthis pageJKLAKSHMI | 44.8/100Mixed-negative evidence69% evidence | BASING | 14.6/35 Revenue 8.7% · PAT 0.5% · OPM change -4 pp 95% evidence | 14.1/25 ROCE 12% · OPM 14% 76% evidence | 10.7/20 P/E 16.3× · PEG — 15% evidence | 5.4/20 RS sector -8.2% · RS bench -25.2% · 1Y -45.5%0 of 10 weeks ahead 70% evidence |
| Exact sum: 14.6 + 14.1 + 10.7 + 5.4 = 44.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 14Birla Corporation LtdBIRLACORPN | 44.5/100Mixed-negative evidence94% evidence | BASING | 18.6/35 Revenue 3.9% · PAT 44.6% · OPM change -1 pp 100% evidence | 11.0/25 ROCE 9.8% · OPM 13% 100% evidence | 9.8/20 P/E 11.4× · PEG 3.92 100% evidence | 5.1/20 RS sector -14% · RS bench -17.8% · 1Y -35.5%0 of 9 weeks ahead 70% evidence |
| Exact sum: 18.6 + 11 + 9.8 + 5.1 = 44.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15Shree Cement LtdSHREECEM | 44.2/100Mixed-negative evidence100% evidence | ASLEEP | 15.4/35 Revenue 12.6% · PAT 9.9% · OPM change -5 pp 100% evidence | 13.3/25 ROCE 10.3% · OPM 20% 100% evidence | 9.5/20 P/E 50× · PEG 0.96 100% evidence | 6.0/20 RS sector -4.1% · RS bench -12.1% · 1Y -24.9%3 of 12 weeks ahead 100% evidence |
| Exact sum: 15.4 + 13.3 + 9.5 + 6 = 44.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 16India Cements LtdINDIACEM | 44.1/100Mixed-negative evidence75% evidence | ASLEEP | 21.0/35 Revenue 7% · PAT 100% · OPM change 7 pp 74% evidence | 3.7/25 ROCE 1.2% · OPM 15% 100% evidence | 6.3/20 P/E 79.6× · PEG — 50% evidence | 13.1/20 RS sector 20% · RS bench -12% · 1Y -12.2%0 of 10 weeks ahead 70% evidence |
| Exact sum: 21 + 3.7 + 6.3 + 13.1 = 44.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 17ACC LtdACC | 42.6/100Mixed-negative evidence94% evidence | BASING | 9.4/35 Revenue 11.6% · PAT -21.1% · OPM change -5 pp 100% evidence | 9.8/25 ROCE 11.2% · OPM 8% 100% evidence | 16.8/20 P/E 12.3× · PEG 0.92 100% evidence | 6.6/20 RS sector -6.7% · RS bench -18.5% · 1Y -31.8%0 of 10 weeks ahead 70% evidence |
| Exact sum: 9.4 + 9.8 + 16.8 + 6.6 = 42.6 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 18K C P LtdKCP | 42.6/100Mixed-negative evidence81% evidence | BASING | 7.8/35 Revenue 6.5% · PAT -17.1% · OPM change -8 pp 95% evidence | 14.3/25 ROCE 12.2% · OPM 8% 95% evidence | 13.2/20 P/E 11.8× · PEG — 50% evidence | 7.3/20 RS sector -14% · RS bench -3.9% · 1Y -20.3%1 of 11 weeks ahead 70% evidence |
| Exact sum: 7.8 + 14.3 + 13.2 + 7.3 = 42.6 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 19Shiva Cement LtdSHIVACEM | 41.0/100Thin evidence · provisional58% evidence | 23.0/35 Revenue 49.5% · PAT 22.5% · OPM change 13.9 pp 71% evidence | 4.5/25 ROCE -1.4% · OPM 12% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 3.5/20 RS sector -27.5% · RS bench -20.8% · 1Y -44.7%0 of 12 weeks ahead 70% evidence | |
| Exact sum: 23 + 4.5 + 10 + 3.5 = 41 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 20The Ramco Cements LtdRAMCOCEM | 40.6/100Mixed-negative evidence94% evidence | BASING | 18.3/35 Revenue 8.6% · PAT 100% · OPM change -6 pp 100% evidence | 9.2/25 ROCE 6.1% · OPM 13% 100% evidence | 1.1/20 P/E 107× · PEG 4.14 100% evidence | 12.0/20 RS sector 11.1% · RS bench -11.1% · 1Y -19%0 of 10 weeks ahead 70% evidence |
| Exact sum: 18.3 + 9.2 + 1.1 + 12 = 40.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 21Ambuja Cements LtdAMBUJACEM | 40.0/100Mixed-negative evidence82% evidence | BASING | 10.6/35 Revenue 7.1% · PAT -5.9% · OPM change -2 pp 95% evidence | 11.0/25 ROCE 5.6% · OPM 17% 76% evidence | 12.4/20 P/E 20.7× · PEG — 50% evidence | 6.0/20 RS sector -10.3% · RS bench -17.9% · 1Y -30.9%0 of 12 weeks ahead 100% evidence |
| Exact sum: 10.6 + 11 + 12.4 + 6 = 40 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 22Deccan Cements LtdDECCANCE | 39.5/100Mixed-negative evidence80% evidence | TURNING | 13.9/35 Revenue 39.4% · PAT -48.2% · OPM change -10.8 pp 95% evidence | 7.4/25 ROCE 3.3% · OPM 7.7% 95% evidence | 9.9/20 P/E 28.1× · PEG — 15% evidence | 8.3/20 RS sector -10.4% · RS bench -18.5% · 1Y -47%0 of 12 weeks ahead 100% evidence |
| Exact sum: 13.9 + 7.4 + 9.9 + 8.3 = 39.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 23Sagar Cements LtdSAGCEM | 35.9/100Mixed-negative evidence72% evidence | ASLEEP | 20.0/35 Revenue 13.4% · PAT 79.7% · OPM change -8 pp 95% evidence | 5.0/25 ROCE 2% · OPM 10% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 0.9/20 RS sector -16.6% · RS bench -23.7% · 1Y -50.3%1 of 12 weeks ahead 100% evidence |
| Exact sum: 20 + 5 + 10 + 0.9 = 35.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 24BIGBLOC Construction LtdBIGBLOC | 34.2/100Adverse evidence72% evidence | BASING | 18.6/35 Revenue 33.5% · PAT 11.3% · OPM change 5.6 pp 71% evidence | 6.0/25 ROCE 1.9% · OPM 7.9% 95% evidence | 8.5/20 P/E 344× · PEG — 15% evidence | 1.1/20 RS sector -15.2% · RS bench -22.3% · 1Y -33.1%1 of 12 weeks ahead 100% evidence |
| Exact sum: 18.6 + 6 + 8.5 + 1.1 = 34.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 25Saurashtra Cement LtdSAURASHCEM | 34.1/100Adverse evidence80% evidence | ASLEEP | 14.5/35 Revenue 7.9% · PAT -52.1% · OPM change -3.7 pp 95% evidence | 5.2/25 ROCE 2.5% · OPM 4.5% 95% evidence | 9.4/20 P/E 38× · PEG — 15% evidence | 5.0/20 RS sector -15.8% · RS bench -23.5% · 1Y -53.7%0 of 12 weeks ahead 100% evidence |
| Exact sum: 14.5 + 5.2 + 9.4 + 5 = 34.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 26Shree Digvijay Cement Co. LtdSHREDIGCEM | 32.1/100Adverse evidence81% evidence | BASING | 11.9/35 Revenue 19.6% · PAT -35% · OPM change -3.5 pp 95% evidence | 8.4/25 ROCE 6.4% · OPM 8.7% 95% evidence | 5.5/20 P/E 56.3× · PEG — 50% evidence | 6.3/20 RS sector -12.4% · RS bench -10.6% · 1Y -24.1%1 of 10 weeks ahead 70% evidence |
| Exact sum: 11.9 + 8.4 + 5.5 + 6.3 = 32.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is JK Lakshmi Cement Ltd's share price today?
JK Lakshmi Cement Ltd trades at ₹506, −43.9% over the past year. The company is valued at ₹6,280 Cr. The stock sits at the very bottom of its 52-week range (₹506–₹870), −21.2% versus its 200-day average. On the tape, the price is in a downtrend, 43 weeks in. — as of 11 September 2026.
What were JK Lakshmi Cement Ltd's latest quarterly results?
JK Lakshmi Cement Ltd reported revenue of ₹1,905 Cr and net profit of ₹108 Cr for the Jun 26 quarter. Revenue rose 9.4% and profit fell 28.0% year on year. Earnings per share were ₹8.70. The operating margin was 14.0%, 4.0 pp lower than a year earlier. — as of 11 September 2026.
What is JK Lakshmi Cement Ltd's revenue?
JK Lakshmi Cement Ltd reported revenue of ₹1,905 Cr in the Jun 26 quarter, +9.4% year on year. For the full FY26 fiscal year, revenue was ₹6,763 Cr (+9.2%). Over the last 10 years revenue compounded at 9.9% a year. — as of 11 September 2026.
What is JK Lakshmi Cement Ltd's profit?
JK Lakshmi Cement Ltd earned ₹108 Cr of net profit in the Jun 26 quarter, −28.0% year on year. Full-year FY26 profit was ₹413 Cr. The operating margin ran 14.0% in the latest quarter. — as of 11 September 2026.
What is JK Lakshmi Cement Ltd's market cap?
JK Lakshmi Cement Ltd's market capitalisation is ₹6,280 Cr at a share price of ₹506. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 11 September 2026.
What is JK Lakshmi Cement Ltd's P/E ratio?
JK Lakshmi Cement Ltd trades at a P/E of 16.3×, at the 29th percentile of its own 11-year range, against a long-run median of 21.6×. This is a comparison with the stock's own history, not a value call — as of 11 September 2026.
Does JK Lakshmi Cement Ltd pay a dividend?
Yes — JK Lakshmi Cement Ltd's dividend payout was 20% of profit in FY26, and it recorded a payout in each of its last 13 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 11 September 2026.
Is JK Lakshmi Cement Ltd overvalued?
On its own history, JK Lakshmi Cement Ltd looks cheap: its P/E of 16.3× has been cheaper only 29% of the time in 11 years (long-run median 21.6×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 11 September 2026.
Is JK Lakshmi Cement Ltd growing?
Not right now — JK Lakshmi Cement Ltd's latest numbers are shrinking: latest-quarter revenue +9.4% year on year, profit −28.0%, and the margin −4.0 pp at 14.0%. The 10-year compound rates are 9.9% (revenue) and 59.0% (profit). The earnings engine currently reads: deteriorating — as of 11 September 2026.
How is JK Lakshmi Cement Ltd performing?
JK Lakshmi Cement Ltd is in a downtrend, 43 weeks in. Its latest quarter's revenue rose 9.4% and profit fell 28.0% year on year. Against the NIFTY 500 it has been behind on a trailing-13-week view for 37 weeks. This describes what the data did, not a rating. — as of 11 September 2026.
What stage is JK Lakshmi Cement Ltd in?
Turning around — profit growth swung from −40.4% at the trough to +0.5% off a 5-quarter-old trough, ROCE holding at 12.0%. The read comes from the last 12 quarters of growth (revenue growth +8.7% latest, profit growth +0.5% latest, eps growth −5.3% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 11 September 2026.
Is JK Lakshmi Cement Ltd in an uptrend?
No — the price is in a downtrend (week 43 of stage 4), trading −21.2% versus its 200-day average and at the very bottom of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 11 September 2026.
Is JK Lakshmi Cement Ltd beating the market?
Not lately — on a trailing-13-week view JK Lakshmi Cement Ltd is currently behind the NIFTY 500 (37 weeks and counting; last ahead the week of 2026-01-16), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.5 years the stock moved +70% against the NIFTY 500's +267% — behind the index over the full window. — as of 11 September 2026.
Will JK Lakshmi Cement Ltd's share price go up?
This page publishes no price forecast for JK Lakshmi Cement Ltd. What it measures instead: the share price is ₹506, the price is in a downtrend 43 weeks in. Its P/E of 16.3× sits at the 29th percentile of its own 11-year range. — as of 11 September 2026.
Who owns JK Lakshmi Cement Ltd?
Promoters hold 45.1% of JK Lakshmi Cement Ltd, foreign institutions 8.6%, domestic institutions 26.6% and the public 19.7% (latest quarter). The biggest move on the register over the last two years: Foreign institutions cut 2.7 points over 8 quarters. — as of 11 September 2026.
Does JK Lakshmi Cement Ltd have too much debt?
It is moderate — JK Lakshmi Cement Ltd's debt-to-equity is 0.67, and operating profit covers the interest bill 5×. FY26 borrowings were ₹2,586 Cr against equity of ₹3,886 Cr. Read the returns on this page with that leverage in mind — as of 11 September 2026.
What is JK Lakshmi Cement Ltd's capex?
JK Lakshmi Cement Ltd spent ₹2,090 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹130 Cr, with ₹277 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 11 September 2026.
What is JK Lakshmi Cement Ltd's cash flow?
JK Lakshmi Cement Ltd generated ₹1,082 Cr of operating cash flow in FY26 and ₹952 Cr of free cash flow after ₹130 Cr of capital spending. Reported profit that year was ₹413 Cr, so operating cash ran ahead of profit. Cash-flow resolution for India is annual. — as of 11 September 2026.
Is JK Lakshmi Cement Ltd's profit real cash?
Yes — over the last 3 fiscal years, 235% of JK Lakshmi Cement Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹1,082 Cr against reported profit of ₹413 Cr. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 11 September 2026.
Where is JK Lakshmi Cement Ltd in its business cycle?
JK Lakshmi Cement Ltd's FY26 operating margin was 15.0%, against a 13-year band of 10.0%–20.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 14.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 11 September 2026.
What could break the JK Lakshmi Cement Ltd story?
The sharpest disagreement: annual EPS moved +41.1% against a −43.9% price move — the market has not yet caught up with the delivery. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 11 September 2026.
Is JK Lakshmi Cement Ltd a stock worth studying right now?
This is not investment advice. The machine read: JK Lakshmi Cement Ltd is cheap for a reason. The P/E sits at the 29th percentile of its own range, and the quarters are still getting worse. The sharpest open question: whether the price catches up with earnings that have already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 11 September 2026.
Not SEBI Registered !! Not Investment advice !!